ZBH: Kolli Sreelakshmi discloses securities transactions

By AlphaYouPublished Oct 2, 2026Form 4

Stocks in this disclosure

Reported activity

Kolli Sreelakshmi

Reporting filer

Kolli Sreelakshmi reported Grant or award in ZIMMER BIOMET HOLDINGS, INC.: 173.901 units of Phantom Stock Units (derivative), dated 2026-09-30. The full Form 4 contains 1 transaction entry.

Disclosed: Oct 2, 2026

Reported details

1 entry

All validated entries in this disclosure
Security	Owner	Date	Code	Action	Quantity	Price	Following holdings	Reporting delay	Filed terms and references
Phantom Stock Units (derivative)	Kolli Sreelakshmi	2026-09-30	A	Grant or award	173.901	0	7,033.757	2 days	Filed terms security Title: Phantom Stock Units id: F1 conversion Or Exercise Price: 89.85 id: F2 transaction Date: 2026-09-30 transaction Form Type: 4 transaction Code: A equity Swap Involved: 0 transaction Shares: 173.901 transaction Price Per Share: 0 transaction Acquired Disposed Code: A id: F3 id: F3 underlying Security Title: Common Stock underlying Security Shares: 173.901 shares Owned Following Transaction: 7033.757 id: F4 direct Or Indirect Ownership: D nature Of Ownership:

Phantom Stock Units (derivative)

Owner: Kolli Sreelakshmi
Date: 2026-09-30
Code: A
Action: Grant or award
Quantity: 173.901
Price: 0
Following holdings: 7,033.757
Reporting delay: 2 days
Filed terms and references: Filed terms
security Title: Phantom Stock Units
id: F1
conversion Or Exercise Price: 89.85
id: F2
transaction Date: 2026-09-30
transaction Form Type: 4
transaction Code: A
equity Swap Involved: 0
transaction Shares: 173.901
transaction Price Per Share: 0
transaction Acquired Disposed Code: A
id: F3
id: F3
underlying Security Title: Common Stock
underlying Security Shares: 173.901
shares Owned Following Transaction: 7033.757
id: F4
direct Or Indirect Ownership: D
nature Of Ownership:

Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.

Filing context

Quantities and prices are shown in the units filed. No trade value is inferred from their product.
Kolli Sreelakshmi: Director.
F1: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
F2: The Conversion or Exercise Price of Derivative Security is 1-for-1.
F3: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.
F4: Includes 17.252 phantom stock units accrued on July 31, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Original sources

SEC ownership filing

Prepared automatically from public filing data. Report a correction.

Security

Owner

Date

Code

Action

Quantity

Price

Following holdings

Reporting delay

Filed terms and references

Phantom Stock Units (derivative)

Kolli Sreelakshmi

2026-09-30

Grant or award

173.901

7,033.757

2 days

Filed terms

security Title: Phantom Stock Units
id: F1
conversion Or Exercise Price: 89.85
id: F2
transaction Date: 2026-09-30
transaction Form Type: 4
transaction Code: A
equity Swap Involved: 0
transaction Shares: 173.901
transaction Price Per Share: 0
transaction Acquired Disposed Code: A
id: F3
id: F3
underlying Security Title: Common Stock
underlying Security Shares: 173.901
shares Owned Following Transaction: 7033.757
id: F4
direct Or Indirect Ownership: D
nature Of Ownership:

Filing context

Quantities and prices are shown in the units filed. No trade value is inferred from their product.

Kolli Sreelakshmi: Director.

F1: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F4: Includes 17.252 phantom stock units accrued on July 31, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.